CDER Plans Five Biosimilars Guidance Documents in 2014

Generic Line
CDER plans to issue highly anticipated guidance in 2014 that addresses specifics about its biosimilars approval pathway and sheds some light on social media usage for pharma companies.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00